|1.||Mayas, María Dolores: 1 article (05/2012)|
|2.||Martínez-Martos, José Manuel: 1 article (05/2012)|
|3.||Ramírez-Expósito, María Jesús: 1 article (05/2012)|
|4.||Martínez-Ferrol, Julia: 1 article (05/2012)|
|5.||Carrera-González, María del Pilar: 1 article (05/2012)|
|6.||Dueñas, Basilio: 1 article (05/2012)|
|7.||Bristow, Michael R: 1 article (10/2003)|
|8.||Weaver, Barbara: 1 article (10/2003)|
|9.||Keller, Rebecca S: 1 article (10/2003)|
|10.||Speth, Robert: 1 article (10/2003)|
|1.||Hypertension (High Blood Pressure)
03/31/1973 - "[Total plasma angiotensinase activity in essential hypertension]."
01/01/1969 - "Plasmatic and erythrocytic angiotensinase activity in subjects with arterial hypertension."
12/01/1967 - "Hypertension and plasma angiotensinase]."
01/01/1966 - "[Plasmatic angiotensinase activity in subjects with arterial hypertension of the essential type and of renal origin]."
12/12/1964 - "PLASMA ANGIOTENSINASE ACTIVITY IN HUMAN HYPERTENSION."
|2.||Renal Insufficiency (Renal Failure)
06/01/1996 - "Although human and animal pregnancy is normally associated with a refractory response to the pressor effect of exogenously infused angiotensin II, patients with preeclampsia, as well as nonpregnant women, are sensitive to the pressor effect of angiotensin II. Our study suggested that the decreased pressor responsiveness to angiotensin II in pregnancy is caused by increased inactivation of angiotensin II by angiotensinase in pregnant serum and the placenta. "
06/01/1996 - "Therefore, it is reasonable to speculate that the increased sensitivity to angiotensin II of preeclampsia is attributable to the decreased degradation of angiotensin II by placental angiotensinase. "
06/01/1996 - "Although vasopressinase and angiotensinase activities increase with advancing gestation in normal pregnant sera, the activities of both enzymes in severe preeclampsia sera were clearly lower than those in normal pregnancy. "
|4.||Breast Neoplasms (Breast Cancer)
05/01/2012 - "Neoadjuvant chemotherapy modifies serum angiotensinase activities in women with breast cancer."
05/01/2012 - "Present results show changes in serum angiotensinase activities in women with breast cancer and in women with breast cancer treated with a neoadjuvant therapy of paclitaxel and anthracycline. "
05/01/2012 - "When compared with healthy controls, women with breast cancer not treated with neoadjuvant chemotherapy, showed a decrease in angiotensinase activity, which support the putative increase of angiotensin II (Ang II) levels, indicating that the tumour process would favour the development of the disease. "
05/01/2012 - "The aim of this study was to investigate the putative changes in serum angiotensinase activities (aminopeptidase N, APN; aminopeptidase B, APB; aminopeptidase A, APA; aspartyl aminopeptidase, ASAP) involved in the renin-angiotensin system (RAS) in women with breast cancer treated or not with a neoadjuvant therapy of paclitaxel and anthracycline and in healthy women volunteers. "
|2.||Peptide Hydrolases (Proteases)
|4.||Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)
|5.||CD13 Antigens (Alanine Aminopeptidase)
|2.||Drug Therapy (Chemotherapy)